Under a settlement with regulators, the company must revamp some operations before resuming sales of its CPAP and ventilator devices in the United States.
Read More Recalls and Bans of Products, Hazardous and Toxic Substances, Compensation for Damages (Law), Food and Drug Administration, Koninklijke Philips Electronics NV
